Indication

Osteosarcoma of bone

Osteosarcoma of bone is a primary malignant neoplasm of the skeletal system characterized by the direct production of osteoid or immature bone matrix by malignant mesenchymal cells. Read more about Osteosarcoma of bone

54 drugs 30 manufacturers

Advertisement

Drugs that treat it

Common Osteosarcoma of bone therapies.

Showing 10–18 of 54 drugs

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
SUN PHARMACEUTI

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
Laboratories Div

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
SAGENT PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Osteosarcoma of bone preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Osteosarcoma of bone.

Osteosarcoma of bone is a primary malignant neoplasm of the skeletal system characterized by the direct production of osteoid or immature bone matrix by malignant mesenchymal cells.

It exhibits a bimodal age distribution, most frequently arising during the adolescent and young adult growth spurt, with a secondary peak among older adults often linked to predisposing conditions such as Paget disease or prior irradiation.

The condition predominantly develops within the metaphyseal regions of long tubular bones, most commonly the distal femur, proximal tibia, and proximal humerus.

Clinically, it typically presents with localized, progressive bone pain and soft tissue swelling, with a marked propensity for cortical destruction and hematogenous metastasis, particularly to the lungs.

Personalize your experience

Follow Osteosarcoma of bone and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it